Cannabinoids DEA Epilepsy Medicine 
Veriheal
APRIL 11, 2022
The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. Drug Enforcement Agency (DEA).
CannaMD
AUGUST 8, 2020
In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system. One more difference?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
DECEMBER 28, 2021
D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. “(Cannabis is) also used in conjunction with other medicines, either to improve their efficacy or to mitigate negative side effects.
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Substances derived from the cannabis plant include marijuana, hemp, and cannabinoids. Executive Summary.
Cannabis Law Report
JULY 12, 2019
International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.
MedicalJane
JUNE 29, 2018
The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. Food and Drug Administration (FDA) had approved only three cannabinoid-based medicines. The Next Move Is On The DEA.
The Joint Blog
JUNE 4, 2021
Those state laws allow medical marijuana to be used to treat ailments like Alzheimer’s, cancer, epilepsy, Crohn’s disease, seizures, hepatitis C and a host of others. The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.
Expert insights. Personalized for you.
104 
Let's personalize your content